p27 as a target for cancer therapeutics
Authors:
- Stacy W BlainSBStacy W Blain
- Howard I ScherHSHoward I Scher
- Carlos Cordon-CardoCCCarlos Cordon-Cardo
- Andrew KoffAKAndrew Koff
- 1 February 2003
- journal article
- review article
- Published by Elsevier in Cancer Cell
- Vol. 3 (2) , 111-115
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- p27 deficiency desensitizes Rb−/− cells to signals that trigger apoptosis during pituitary tumor developmentOncogene, 2003
- Overexpression of p27Kip1 induces growth arrest and apoptosis in an oral cancer cell lineOral Oncology, 2002
- Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27Kip1The Prostate, 2002
- Pathway-specific tumor suppressionCancer Cell, 2002
- Expression and Subcellular Localization of the Cyclin-Dependent Kinase Inhibitor p27Kip1 in Epithelial Ovarian CancerGynecologic Oncology, 2001
- Disruption of TGF-β growth inhibition by oncogenic ras is linked to p27Kip1 mislocalizationOncogene, 2000
- TGFβ Signaling in Growth Control, Cancer, and Heritable DisordersCell, 2000
- A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27 -Deficient MiceCell, 1996
- Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27Cell, 1996
- Mice Lacking p27 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary TumorsCell, 1996